We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MDGL market cap is 3.84B. The company's latest EPS is USD -18.7778 and P/E is -10.29.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -80.41M | -85.3M | -78.34M | -86.45M | -98.53M |
| Net Income | -81.2M | -85.91M | -76.9M | -85.8M | -98.74M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -94.97M | -206.67M | -242.48M | -293.57M | -380.5M |
| Net Income | -83.95M | -202.24M | -241.85M | -295.35M | -373.63M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 158.64M | 362.57M | 332.45M | 302.46M | 237.96M |
| Total Liabilities | 147.97M | 165.18M | 182.31M | 198.96M | 215.72M |
| Total Equity | 10.67M | 197.39M | 150.14M | 103.51M | 22.25M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 442.06M | 287M | 273.33M | 362.57M | 640.55M |
| Total Liabilities | 25.49M | 47.03M | 77.23M | 165.18M | 235.21M |
| Total Equity | 416.57M | 239.97M | 196.11M | 197.39M | 405.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -166.34M | -224.86M | -84.07M | -159.38M | -244.3M |
| Investing | 140.3M | 206.69M | -186.86M | -190.6M | -140.4M |
| Financing | 49.11M | 313.45M | 52.69M | 95.62M | 115.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.62M | -157.56M | -183.92M | -224.86M | -324.23M |
| Investing | 30.71M | 159.78M | -5.06M | 206.69M | -502.52M |
| Financing | 235k | 5.09M | 171.24M | 313.45M | 595.12M |
| Market Cap | 3.84B |
| Price to Earnings Ratio | -10.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 38.49 |
| Price to Book Ratio | 9.49 |
| Dividend Yield | - |
| Shares Outstanding | 19.9M |
| Average Volume (1 week) | 608.09k |
| Average Volume (1 Month) | 405.64k |
| 52 Week Change | -34.42% |
| 52 Week High | 322.67 |
| 52 Week Low | 119.7604 |
| Spread (Intraday) | 28.82 (13.1%) |
| Company Name | Madrigal Pharmaceuticals Inc |
| Address |
2711 centerville road wilmington, delaware 19808 |
| Website | https://www.madrigalpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
